Lv1
20 积分 2025-10-15 加入
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
1个月前
已完结
Hsu J, Francis JH, Ahmad S. Ocular toxicities of fibroblast growth factor receptor inhibitors: A review. Surv Ophthalmol. 2024 Jan-Feb;69(1):34-41. doi: 10.1016/j.survophthal.2023.09.007. Epub 2023 Sep 28. PMID: 37777119
5个月前
已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
7个月前
已完结
皖公网安备34019202002308
